Clinical implications of the STAR* D trial

A John Rush, S Jain - Antidepressants: From Biogenic Amines to New …, 2019 - Springer
citalopram might decline switching but accept augmentation … of treatment with buspirone
(20.6%) than bupropion-SR (12.5… (either citalopram combined with bupropion-SR or buspirone

Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant

…, I Angelescu, D Baumeister… - Therapeutic …, 2016 - journals.sagepub.com
… in citalopram and bupropion and citalopram and buspirone … no statistical differences between
bupropion SR and placebo on … ’ in comparing bupropion with buspirone augmentation. …

[HTML][HTML] Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning

P Kølbæk, O Mors, CU Correll, SD Østergaard - Schizophrenia, 2023 - nature.com
… (SR) and buspirone augmentation of citalopram, finding that bupropion-SR was superior in
… However, this study was based on re-analysis of data from a placebo-controlled clinical trial

Pharmacotherapy of major depression in late life: what is the role of new agents?

K Patel, PS Abdool, TK Rajji… - Expert Opinion on …, 2017 - Taylor & Francis
… a warning about the potential of citalopram to induce an increase … use of atypical antipsychotic
as augmenting agents in non-… to a combination of an SSRI and buspirone, which has been …

Adjunctive strategies for treatment-resistant depression

ME Thase - Managing Treatment-Resistant Depression, 2022 - Elsevier
… , the STAR*D research project included a head-to-head trial … ) or “augmentation” of
citalopram by either buspirone or … In summary, the results of three RCTs indicate that buspirone

Clinical research challenges posed by difficult-to-treat depression

AJ Rush, HA Sackeim, CR Conway… - Psychological …, 2022 - cambridge.org
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation
of citalopram in the STAR*D trial. Acta Psychiatrica Scandinavica, 125, 342–348. doi: …

Major depressive disorder: how to evaluate and manage patients with psychiatric and medical comorbidities

SM Wang, CU Pae - Mental Disorders in Primary Care: A Guide …, 2017 - books.google.com
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone
augmentation of citalopram in the STAR* D trial. Acta Psychiatr Scand, 125/4: 342–8. …

[HTML][HTML] Obesogenic medications and weight gain over 24 weeks in patients with depression: results from the GUIDED study

JG Fiedorowicz, L Brown, J Li, SV Parikh… - Psychopharmacology …, 2021 - ncbi.nlm.nih.gov
… VAST-D trial, the bupropion arms (change or augmentation) … from an initially randomized
clinical trial in which clinically-… the referent comparator citalopram although unexpectedly so too …

Recent findings of the comparative efficacy and tolerability of antidepressants for major depressive disorder: do we now know what to prescribe?

MV Rudorfer - CNS drugs, 2018 - Springer
… , it too is often used as an augmentation agent when added to a partially … STAR*D effectiveness
trial [20]), often to increase energy or to combat SSRI-associated sexual adverse effects

[图书][B] Measurement-based care in mental disorders

P Bech - 2016 - Springer
Outcomes on the pharmacopsychometric triangle in bupropion-SR versus buspirone
augmentation of citalopram in the STAR*D trial. Acta Psychiatrica Scandinavica, 125(4), 342–348. …